Organization
Tisento Therapeutics
6 clinical trials
Clinical trial
Phase 2b Randomized, Double-blind, Placebo-controlled Crossover Study Evaluating the Efficacy and Safety of Zagociguat in Participants With MELAS (PRIZM)Status: Not yet recruiting, Estimated PCD: 2024-09-01
Clinical trial
A Phase 2a Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of CY6463 When Administered to Participants With Alzheimer's Disease and Vascular PathologyStatus: Terminated, Estimated PCD: 2022-11-28
Clinical trial
A Double-blinded, Randomized, Placebo-controlled, Multiple-ascending-dose Study to Assess the Safety and Pharmacokinetics of CY6463 in Participants With Stable SchizophreniaStatus: Completed, Estimated PCD: 2022-04-18
Clinical trial
A Phase 1 Study Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics of IW-6463 When Administered to Healthy Volunteers as Single Ascending Doses, as Multiple Ascending Doses, and Under Fed Versus Fasting ConditionsStatus: Completed, Estimated PCD: 2019-10-22
Clinical trial
Evaluating the Safety, Tolerability, and Pharmacodynamic Properties of IW-6463 in Healthy Elderly SubjectsStatus: Terminated, Estimated PCD: 2020-05-22
Clinical trial
A Phase 2a Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Study in Individuals With Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like Episodes (MELAS)Status: Terminated, Estimated PCD: 2022-01-23